Sabra Healthcare REIT (NASDAQ:SBRA) Stock Picked Up by Analysts at Huntington Sec

Investment analysts at Huntington Sec began coverage on shares of Sabra Healthcare REIT (NASDAQ:SBRA) in a report issued on Monday, Zacks reports. The brokerage set a “strong-buy” rating on the real estate investment trust’s stock.

SBRA has been the topic of a number of other reports. Mizuho set a $21.00 price objective on Sabra Healthcare REIT in a report on Monday, August 31st. Huntington initiated coverage on Sabra Healthcare REIT in a research report on Thursday, September 10th. They issued an “outperform” rating and a $23.00 target price on the stock. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Finally, Citigroup restated a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $21.50.

Sabra Healthcare REIT Price Performance

Shares of SBRA opened at $20.35 on Monday. The firm has a market capitalization of $5.20 billion, a PE ratio of 72.68, a price-to-earnings-growth ratio of 1.79 and a beta of 0.68. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07. Sabra Healthcare REIT has a 1-year low of $17.53 and a 1-year high of $22.77. The company’s fifty day moving average price is $19.85 and its 200-day moving average price is $19.97.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.05). The firm had revenue of $249.57 million during the quarter, compared to analyst estimates of $236.64 million. Sabra Healthcare REIT had a net margin of 7.78% and a return on equity of 2.56%. Sabra Healthcare REIT’s revenue was up 31.4% on a year-over-year basis. During the same period in the previous year, the company earned $0.38 earnings per share. On average, equities research analysts predict that Sabra Healthcare REIT will post 1.52 EPS for the current year.

Insiders Place Their Bets

In other Sabra Healthcare REIT news, CEO Richard Matros sold 200,000 shares of the company’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the transaction, the chief executive officer owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. This represents a 10.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.09% of the company’s stock.

Hedge Funds Weigh In On Sabra Healthcare REIT

Large investors have recently bought and sold shares of the business. Principal Financial Group Inc. lifted its holdings in Sabra Healthcare REIT by 0.4% during the first quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock valued at $481,755,000 after purchasing an additional 98,770 shares in the last quarter. Lasalle Investment Management Securities LLC increased its stake in Sabra Healthcare REIT by 8.2% during the 1st quarter. Lasalle Investment Management Securities LLC now owns 3,824,622 shares of the real estate investment trust’s stock worth $73,547,000 after buying an additional 290,405 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in Sabra Healthcare REIT by 7.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust’s stock worth $71,640,000 after buying an additional 269,793 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Sabra Healthcare REIT by 6.8% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,208,600 shares of the real estate investment trust’s stock valued at $61,701,000 after acquiring an additional 203,226 shares during the last quarter. Finally, Rush Island Management LP acquired a new position in shares of Sabra Healthcare REIT during the first quarter valued at approximately $30,735,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT News Summary

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Sabra raised its 2026 guidance: EPS is now projected at $1.54–$1.55, above the $1.52 consensus, and the midpoint of normalized FFO guidance increased by $0.005 per share. Management also expects 7%–8% year-over-year earnings growth. Sabra Health Care: 3 Key Takeaways for Long-Term Investors
• Positive Sentiment: Third-quarter revenue of about $249.6 million exceeded analyst estimates of $236.6 million and rose 31.4% year over year. Adjusted FFO also topped consensus, according to Zacks. Sabra Healthcare Tops Q3 FFO and Revenue Estimates
• Positive Sentiment: Senior-housing operating portfolio occupancy reached 89.2%, supporting the company’s growth outlook. Sabra also declared a quarterly dividend of $0.30 per share, equivalent to a 6.0% yield based on the provided data. Sabra Reports Third Quarter 2026 Results; Updates 2026 Guidance
• Neutral Sentiment: Sabra aims to increase its senior housing operating portfolio (SHOP) to 50% of its portfolio by year-end 2027, while management sees further upside from nursing-home asset optimization and lease negotiations. The strategy offers growth potential but depends on execution. Sabra Expects Earnings Growth and Targets More SHOP Exposure
• Negative Sentiment: Reported third-quarter net income was $0.11 per diluted share, below the $0.16 analyst consensus and down from $0.38 a year earlier. This earnings miss may temper the positive impact of stronger revenue, FFO, and guidance. Sabra Q3 Earnings Results

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.